✦ LIBER ✦

P-600 Stage IIIA(N2)-IIIB non small cell lung cancer (NSCLC):Short-schedule cisplatin and vinorelbine as induction chemotherapy

✍ Scribed by Zucali, P.; Cavina, R.; Soto Parra, H.; Campagnoli, E.; De Vincenzo, E.; Garassino, I.; Alloisio, M.; Balzarini, L.; Ceresoli, G.; Santoro, A.

Book ID: 118573504
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 146 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(05)81093-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carboplatin (CBDCA) and paclitaxel (TAX)

Carboplatin (CBDCA) and paclitaxel (TAX) as induction chemotherapy in stage IIIA–IIIB in non small cell lung cancer (NSCLC)

✍ Tamberi, S.; Gallerani, E.; Bazzocchi, R.; Zompatori, M.; Martinelli, G.; Schiav 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Vinorelbine (VNR)-cisplatin (C) combinat

Vinorelbine (VNR)-cisplatin (C) combination neoadjuvant chemotherapy in stage IIIB non-small cell lung cancer (NSCLC): results after 2 years

✍ Cigolari, S; Curcio, C; Massimo, M; Sessa, R; Palmieri, EA; Vasta, M; Maiorino, 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 131 KB

P-461 Modified weekly schedule of cispla

P-461 Modified weekly schedule of cisplatin-vinorelbine chemotherapy in stages IIIB-IV non small cell lung cancer (NSCLC). Preliminary results about 18 patients

✍ Boussem, H.; Benna, F.; Bourguiba, M.; Hamzaoui, A.; Kilani, T.; Lagha, M.; Megd 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 277 KB

P-253 Anemia as a prognostic factor in i

P-253 Anemia as a prognostic factor in induction chemotherapy for stage IIIA N2 non small cell lung cancer (NSCLC)

✍ Burkes, Ronald L.; Card, Cynthia M.; Ginsberg, Robert J.; Shepherd, Frances A.; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Survival by N-status post chemotherapy i

Survival by N-status post chemotherapy induction for stage IIIA (N2) non-small cell lung cancer (NSCLC)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Gemcitabine and cisplatin as induction c

Gemcitabine and cisplatin as induction chemotherapy in stage IIIAN2/IIIB Non Small Cell Lung Cancer (NSCLC). A mono-institutional phase II study with 21 days schedule

✍ Migliorino, M; De Marinis, F; Nelli, F; Facciolo, F; Ammaturo, M.V; Ramponi, S; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB